Virios Therapeutics (VIRI) Stock Chart & Stock Price History $5.46 -0.25 (-4.29%) As of 05/20/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock Virios Therapeutics Stock Price Performance The Virios Therapeutics (VIRI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 2,584.18%, with a year-to-date return of 91.75%. In the past month, the stock has increased 1.77%, reflecting recent market activity. As of the latest close, Virios Therapeutics traded at $5.47 with a market cap of $105.25 million and volume of 103,884 shares. Receive VIRI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.46%1 Month Performance+1.77%3 Month Performance-7.06%Year-To-Date Performance+91.75%1 Year Performance+2,584.18% VIRI Stock Chart for Thursday, May, 22, 2025 VIRI Chart by TradingView Virios Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$5.32$5.47+2.73%$5.70$5.35103,884 shs$105.25 million05/20/2025$5.32$5.32$5.73$5.16140,614 shs$102.45 million05/19/2025$5.32$5.32$5.73$5.16140,614 shs$102.45 million05/16/2025$4.85$5.49+13.20%$5.79$4.91393,421 shs$105.73 million05/15/2025$4.85$4.85$4.94$4.71130,195 shs$93.40 million05/14/2025$4.78$4.85+1.46%$4.99$4.7169,728 shs$93.40 million05/13/2025$4.56$4.78+4.82%$4.98$4.53209,771 shs$92.05 million05/12/2025$4.56$4.56$4.78$4.47104,583 shs$87.82 million05/09/2025$4.52$4.56+0.88%$4.94$4.4091,031 shs$87.82 million05/08/2025$4.52$4.52$4.68$4.3298,543 shs$87.05 million Get the Latest News and Ratings for VIRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$4.82$4.52-6.22%$4.68$4.3298,543 shs$87.05 million05/06/2025$5.02$4.82-3.98%$5.20$4.76106,945 shs$92.82 million05/05/2025$5.02$5.02$5.45$4.90153,971 shs$96.68 million05/02/2025$5.48$5.36-2.19%$5.55$5.20116,396 shs$103.22 million05/01/2025$5.41$5.48+1.29%$5.48$5.02182,458 shs$105.53 million04/30/2025$5.59$5.41-3.22%$5.71$5.14290,924 shs$104.19 million04/29/2025$5.53$5.59+1.08%$5.90$5.27256,888 shs$107.65 million04/28/2025$5.53$5.53$6.05$5.41352,479 shs$106.50 million04/25/2025$5.87$5.87$6.49$5.621.23 million shs$113.04 million04/24/2025$5.46$5.87+7.51%$6.49$5.621.23 million shs$113.04 million04/23/2025$5.37$5.46+1.68%$5.75$4.54728,848 shs$105.15 million04/22/2025$4.27$5.37+25.76%$7.73$5.2121.18 million shs$103.42 million04/21/2025$4.27$4.27$5.09$3.602.00 million shs$82.23 million Related Companies Organogenesis Stock Price Chart PureTech Health Stock Price Chart MBX Biosciences Stock Price Chart Maze Therapeutics Stock Price Chart COMPASS Pathways Stock Price Chart Precigen Stock Price Chart Prothena Stock Price Chart Autolus Therapeutics Stock Price Chart Kamada Stock Price Chart Verve Therapeutics Stock Price Chart Receive VIRI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIRI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virios Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virios Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
